Data protection Impressum

R&D

AB2 Bio has received a USD 30 million payment after Japanese pharmaceutical company Nippon Shinyaku exercised its option to commercialize Tadekinig alfa in the United States, with up to USD 600 million in further milestone and royalty payments.

AB2 Bio receives USD 30 million as Nippon Shinyaku takes up US rights

3 August 2026

Actival, a CSEM spin-off based in Neuchâtel, has been awarded a CHF 1.4 million grant from Innosuisse to accelerate the development and market launch of its patented Active Splints, a new generation of dental aligners that dispense antibacterial fluid and fluoride.

Actival secures a CHF 1.4 million Innosuisse grant for its smart dental aligners

3 August 2026

MoleSense and Impli, both based at the Biopôle life sciences campus, have been selected by Germany's Federal Agency for Breakthrough Innovation to develop biosensors capable of continuously measuring at least four hormones over seven days.

MoleSense and Impli selected for the SPRIND Challenge on continuous hormone monitoring

3 August 2026

Immitra Bio, based in Plan-les-Ouates in the canton of Geneva, has closed an upsized CHF 2.4 million pre-seed round to advance its scalable in-vivo gene editing platform and its lead candidate for an inherited anemia.

Immitra Bio raises CHF 2.4 million to advance its in-vivo gene editing platform

3 August 2026

SWISSto12, the Renens-based space technology company and EPFL spin-off, has closed a USD 70 million Series C round to meet growing demand for its payloads and satellites across multiple orbits.

SWISSto12 raises USD 70 million to meet growing multi-orbit satellite demand

16 July 2026

Bearmind, a Lausanne-based sports-tech start-up, has been named one of eleven winners of the 2026 WIPO Global Awards, taking the Sport category from a field of more than 1,300 applicants across 126 countries.

Lausanne’s Bearmind wins the Sport category at the 2026 WIPO Global Awards

13 July 2026

Neur.on, the Fribourg-based LegalTech behind the AI legal translation platform Corrext, has joined forces with Legal 230, Europe's leading legal translation network, while preserving Swiss data hosting and its Fribourg team.

Fribourg LegalTech Neur.on partners with European leader Legal 230

8 July 2026

In a world first, physicists at the University of Fribourg, with an international team, have used ultrafast light pulses to briefly create a topological state of matter in a semiconductor, confirming a theory formulated over a decade ago.

University of Fribourg physicists create a new state of matter with light pulses

8 July 2026

CCRAFT, a Neuchâtel-based CSEM spin-off operating the world's first independent foundry for thin-film lithium niobate photonic chips, has closed a USD 7.8 million funding round to build industrial-scale manufacturing capacity.

CCRAFT raises USD 7.8 million to scale up its photonic chip foundry

6 July 2026

AC Immune will receive a USD 4 million research grant from The Vijay and Marie Goradia Charitable Foundation to extend Part 1 of the Phase 2 VacSYn trial of ACI-7104, its immunotherapy for early Parkinson's disease.

AC Immune secures USD 4 million grant to advance its Parkinson’s immunotherapy

6 July 2026

1 2 3 4 5 6 7 … 18